EORTC trial opens for patients with recurrent grade II or III meningioma
2015-09-02
(Press-News.org) Meningiomas are a type of brain tumor that form on membranes covering the brain and spinal cord just inside the skull. They occur at an annual incidence of up to 13 per 100 000, and approximately 20% of these exhibit aggressive behavior and burden patients with tumor recurrences as well as infiltration of the surrounding bone, brain, or soft tissue.
Dr. Matthias Preusser of the Medical University Vienna - General Hospital AKH and Coordinator of this study says, "High-grade meningiomas are characterized by prominent infiltration with tumor-associated macrophages and angiogenesis. These characteristics, however, are among the therapeutic targets of trabectedin."
The aim of the recently opened comparative randomized phase II EORTC 1320 trial is to analyze prospectively collected data on activity, safety and quality of life of trabectedin therapy in patients with recurrent high-grade meningioma.
Dr. Preusser adds, "In fact, we saw very promising activity of trabectedin against meningioma cell lines in laboratory investigations and favorable disease stabilization in a patient with heavily pretreated malignant meningioma, and these findings provide us with a rationale for further studying the potential efficacy of trabectedin in grade II or III meningioma."
INFORMATION:
EORTC trial 1320 is coordinated by the EORTC Brain Tumor Group and plans to accrue 86 patients with recurrent grade II or III meningioma at 47 sites located in ten countries: Austria, Belgium, France, Germany, Italy, Norway, Spain, Switzerland, The Netherlands, and the United Kingdom.
This EORTC sponsored trial is supported by an Educational Grant from PharmaMar.
ELSE PRESS RELEASES FROM THIS DATE:
2015-09-02
This news release is available in German. What did the universe look like shortly after it came into being? The ALICE experiment (A Large Ion Collider Experiment) at CERN in Switzerland concerns itself with this question. At the largest particle accelerator in the world, the Large Hadron Collider (LHC), researchers let lead nuclei and protons collide at the highest beam energies to date. The temperatures thereby created are 100,000 times higher than those in the center of the Sun. "A state is created that is very similar to the one after the Big Bang," explains Laura ...
2015-09-02
(Boston)--There is strong evidence that the protein complex APC/C may function as a tumor suppressor in multiple cancers including lymphoma, colorectal and breast cancer, and now melanoma. A new study has revealed that a genetic mutation leading to repression of a specific protein, Cdh1, which interacts with APC/C, is present in melanoma cancer cells.
The study, led by researchers at Boston University School of Medicine (BUSM), reports sporadic mutations in the APC/C protein complex, specifically in the essential protein component Cdh1, which may predispose humans to ...
2015-09-02
The study, published in the journal Financial Stability, introduces a new method that allows researchers to estimate the systemic risk that emerge from multiple layers of connectivity.
"Systemic risk is the risk that a significant part of the financial system stops working--that it cannot perform its function," says IIASA Advanced Systems Analysis program researcher Sebastian Poledna, who led the study. For example if a major bank fails, it could trigger the failure of other financial institutions that are linked to it through loans, derivatives, securities, and foreign ...
2015-09-02
Scientists have developed a simple process to treat waste coffee grounds to allow them to store methane. The simple soak and heating process develops a carbon capture material with the additional environmental benefits of recycling a waste product.
The results are published today, 03 September 2015, in the journal Nanotechnology.
Methane capture and storage provides a double environmental return - it removes a harmful greenhouse gas from the atmosphere that can then be used as a fuel that is cleaner than other fossil fuels.
The process developed by the researchers, ...
2015-09-02
Although most of the world's biodiversity is below ground, surprisingly little is known about how it affects ecosystems or how it will be affected by climate change. A new study demonstrates that soil bacteria and the richness of animal species belowground play a key role in regulating a whole suite of ecosystem functions on Earth. The authors call for far more attention to this overlooked world of worms, bugs and bacteria in the soil.
Ecosystem functions such as carbon storage and the availability of nutrients are linked to the bugs, bacteria and other microscopic ...
2015-09-02
CAMBRIDGE, Mass. (September 2, 2015) - Altering the protein recycling complexes in human cells, including cancer cells, allows the cells to resist treatment with a class of drugs known as proteasome inhibitors, according to Whitehead Institute scientists.
"This is why some cancers can be so difficult to treat with chemotherapy, because the cells can be in different states--some sensitive to treatment and some resistant to treatment, all in the same tumor," says Sandro Santagata, a former visiting scientist in the lab of Whitehead Member Susan Lindquist. Santagata is now ...
2015-09-02
Their pregnancies are carried by the males but, when it comes to breeding, seahorses have more in common with humans than previously thought, new research from the University of Sydney reveals.
Seahorses are famed for being part of the only family in the animal kingdom (Syngnathidae) in which the male is responsible for pregnancy. What hasn't been known until now is the degree to which male seahorses nourish and protect their embryos in their brood pouch during the 24-day gestation period.
Findings co-authored by Dr Camilla Whittington from the University's School of ...
2015-09-02
A new study, published today in the British Journal of Pharmacology, by scientists from Royal Holloway, University of London, St George's, University of London and University of Surrey have identified that a drug related to commonly used diabetes treatments provides protection against terminal blood loss.
Massive blood loss often leads to death, and when blood transfusions are unavailable, drugs are currently being tested that can keep people alive until they get to hospital. Understanding how these drugs work, and finding improved drugs, has up to now proved difficult. ...
2015-09-01
MAYWOOD, Ill. - In carefully selected patients, minimally invasive surgery is enabling physicians to stop strokes in their tracks.
And as more stroke patients undergo such procedures, physicians are debating the best way to anesthetize them. Should patients be put under general anesthesia, rendering them unconscious and motionless? Or should they undergo conscious sedation, in which they remain conscious, but are sedated and do not feel pain?
In the September, 2015 issue of the Journal of Stroke and Cerebrovascular Diseases, Loyola University Medical center anesthesiologists ...
2015-09-01
At the International Conference on Intelligent Robots and Systems in September, members of the Singapore-MIT Alliance for Research and Technology (SMART) and their colleagues will describe an experiment conducted over six days at a large public garden in Singapore, in which self-driving golf carts ferried 500 tourists around winding paths trafficked by pedestrians, bicyclists, and the occasional monitor lizard.
The experiments also tested an online booking system that enabled visitors to schedule pickups and drop-offs at any of 10 distinct stations scattered around the ...
LAST 30 PRESS RELEASES:
[Press-News.org] EORTC trial opens for patients with recurrent grade II or III meningioma
